PARAMETER: heart failure agent to treat hypertension
Recorded at: ESC 2015 (London, United Kingdom) on Monday, August 31, 2015
ESC 2015 The PARAMETER study evaluated LCZ696, the agent that was found to be effective against heart failure in the PARADIGM-HF, in another population of patients with systolic hypertension. Prof. Bryan Williams discusses the results.
The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.